Why FDA Approval Matters for Weight Loss Injections Choosing FDA approved GLP-1 medications means the treatment has been evaluated for safety, effectiveness, and long-term use
The answer depends on several factors, including the cause and severity of deficiency, your overall health, and how long symptoms have been present
The ingredients in each of the compounded products are as follows: COMPOUNDED VIALS : Semaglutide Active Ingredient semaglutide Inactive Ingredients benzyl alcohol, dibasic sodium phosphate, and sterile water for injection Tirzepatide Active Ingredient tirzepatide Inactive Ingredients benzyl alcohol and sterile water for injection COMPOUNDED PREFILLED SYRINGES : Semaglutide Active Ingredient semaglutide Inactive Ingredients sodium biphasic dihydrogen phosphate, sodium chloride, hydrochloric acid, and sodium hydroxide Tirzepatide Active Ingredient tirzepatide Inactive Ingredients sodium biphasic dihydrogen phosphate, sodium chloride, hydrochloric acid, and sodium hydroxide Who is not a candidate for this medication
It is also approved for chronic weight management in non-diabetic individuals with obesity or overweight with related health conditions
Her public disclosure could be whats needed to destigmatize obesity, Northeastern University experts say, and encourage people who struggle with their weight to consider GLP-1 treatments